IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on November 2, 2026

Nov. 2, 2026

NowVertical Announces Release of Units from Escrow to Teraz Fund

Indeterminate GlobeNewswire

Nov. 2, 2026

Asure Software and Vertex Announce Strategic Alliance to Expand Payroll Tax Management Reach

Indeterminate GlobeNewswire

Nov. 2, 2026

A3P Biomedical appoints Matt Franklin as President, North America to accelerate US market access for Stockholm3

Indeterminate GlobeNewswire

Nov. 2, 2026

Teva to Discontinue Phase 2 TOPAS-MSA Study of emrusolmin (TEV-‘286) Following Interim Futility Analysis

Indeterminate GlobeNewswire

Nov. 2, 2026

CytomX Therapeutics to Present at Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

New SEON Survey Finds U.S. Consumers Are Embracing AI Agents, but 65% Would Blame the AI Company if One Commits Fraud

Indeterminate GlobeNewswire

Nov. 2, 2026

Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 2, 2026

Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data

Indeterminate GlobeNewswire

Nov. 2, 2026

Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.

Indeterminate GlobeNewswire

Nov. 2, 2026

Eyconis to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Humacyte To Announce 2026 Third Quarter Financial Results and Provide Business Update on November 10, 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation

Indeterminate GlobeNewswire

Nov. 2, 2026

NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology

Indeterminate GlobeNewswire

Nov. 2, 2026

Theriva™ Biologics anuncia la venta de SYN-004 (ribaxamasa) y la cartera de enzimas degradadoras de antibióticos asociada a Biossil Labs Inc.

Indeterminate GlobeNewswire

Nov. 2, 2026

CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer

Indeterminate GlobeNewswire

Nov. 2, 2026

General Fusion to Host Third Quarter 2026 Results Conference Call

Indeterminate GlobeNewswire

Nov. 2, 2026

RANE Partners with ISM to Help Global Supply Chain Professionals Get Ahead of Disruption

Indeterminate GlobeNewswire